Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

✍ Scribed by A. H. H. Van Boxel-Dezaire; S. C. J. Van Trigt-Hoff; J. Killestein; H. M. Schrijver; J. C. Van Houwelingen; C. H. Polman; L. Nagelkerken

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 182 KB
• Volume: 48
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/1531-8249(200009)48:3<313::aid-ana5>3.0.co;2-9